TrialEBioMedicine2016

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration.

Ian J Constable et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.